Search research articles
Contact Us
Filters
Showing results (731-740 of 903) with videos related to
Page
of 91
Sort By:
Genes & Development
|
October 12, 2010
Notch dimerization is required for leukemogenesis and T-cell development
Hudan Liu, Anthony W S Chi, Kelly L Arnett, et al.
International Journal of Gynecological Cancer : Official Journal of the International Gynecological Cancer Society
|
August 18, 2019
TRUST: Trial of Radical Upfront Surgical Therapy in advanced ovarian cancer (ENGOT ov33/AGO-OVAR OP7)
Alexander Reuss, Andreas du Bois, Philipp Harter, et al.
Gynecologic Oncology
|
August 8, 2006
The addition of extensive upper abdominal surgery to achieve optimal cytoreduction improves survival in patients with stages IIIC-IV epithelial ovarian cancer
Eric L Eisenhauer, Nadeem R Abu-Rustum, Yukio Sonoda, et al.
Journal of Korean Medical Science
|
January 14, 1999
Low prevalence of activated protein C resistance and coagulation factor V Arg506 to Gln mutation among Korean patients with deep vein thrombosis
T W Kim, W K Kim, J H Lee, et al.
Bone Marrow Transplantation
|
October 21, 2000
Veno-occlusive disease of the liver after allogeneic bone marrow transplantation for severe aplastic anemia
J H Lee, K H Lee, S J Choi, et al.
Gynecologic Oncology
|
February 24, 2009
Sentinel lymph node mapping for grade 1 endometrial cancer: is it the answer to the surgical staging dilemma?
Nadeem R Abu-Rustum, Fady Khoury-Collado, Neeta Pandit-Taskar, et al.
Gynecologic Oncology
|
September 7, 2018
Perioperative epidural use and survival outcomes in patients undergoing primary debulking surgery for advanced ovarian cancer
Jill H Tseng, Renee A Cowan, Anoushka M Afonso, et al.
Gynecologic Oncology
|
October 23, 2024
Five-year quality-of-life assessment by urinary diversion type after pelvic Exenterations
Sara Moufarrij, Christian Dagher, Olga T Filippova, et al.
The Oncologist
|
February 3, 2016
Elevation of Urinary 2-Hydroxyglutarate in IDH-Mutant Glioma
Amir T Fathi, Brian V Nahed, Seth A Wander, et al.
Gynecologic Oncology
|
February 28, 2017
Optimal primary management of bulky stage IIIC ovarian, fallopian tube and peritoneal carcinoma: Are the only options complete gross resection at primary debulking surgery or neoadjuvant chemotherapy?
Vasileios D Sioulas, Maria B Schiavone, David Kadouri, et al.
Page
of 91
Search research articles
Search
Showing results (731-740 of 903) with videos related to
Sort By:
Page
of 91
Genes & Development
|
October 12, 2010
Notch dimerization is required for leukemogenesis and T-cell development
Hudan Liu, Anthony W S Chi, Kelly L Arnett, et al.
International Journal of Gynecological Cancer : Official Journal of the International Gynecological Cancer Society
|
August 18, 2019
TRUST: Trial of Radical Upfront Surgical Therapy in advanced ovarian cancer (ENGOT ov33/AGO-OVAR OP7)
Alexander Reuss, Andreas du Bois, Philipp Harter, et al.
Gynecologic Oncology
|
August 8, 2006
The addition of extensive upper abdominal surgery to achieve optimal cytoreduction improves survival in patients with stages IIIC-IV epithelial ovarian cancer
Eric L Eisenhauer, Nadeem R Abu-Rustum, Yukio Sonoda, et al.
Journal of Korean Medical Science
|
January 14, 1999
Low prevalence of activated protein C resistance and coagulation factor V Arg506 to Gln mutation among Korean patients with deep vein thrombosis
T W Kim, W K Kim, J H Lee, et al.
Bone Marrow Transplantation
|
October 21, 2000
Veno-occlusive disease of the liver after allogeneic bone marrow transplantation for severe aplastic anemia
J H Lee, K H Lee, S J Choi, et al.
Gynecologic Oncology
|
February 24, 2009
Sentinel lymph node mapping for grade 1 endometrial cancer: is it the answer to the surgical staging dilemma?
Nadeem R Abu-Rustum, Fady Khoury-Collado, Neeta Pandit-Taskar, et al.
Gynecologic Oncology
|
September 7, 2018
Perioperative epidural use and survival outcomes in patients undergoing primary debulking surgery for advanced ovarian cancer
Jill H Tseng, Renee A Cowan, Anoushka M Afonso, et al.
Gynecologic Oncology
|
October 23, 2024
Five-year quality-of-life assessment by urinary diversion type after pelvic Exenterations
Sara Moufarrij, Christian Dagher, Olga T Filippova, et al.
The Oncologist
|
February 3, 2016
Elevation of Urinary 2-Hydroxyglutarate in IDH-Mutant Glioma
Amir T Fathi, Brian V Nahed, Seth A Wander, et al.
Gynecologic Oncology
|
February 28, 2017
Optimal primary management of bulky stage IIIC ovarian, fallopian tube and peritoneal carcinoma: Are the only options complete gross resection at primary debulking surgery or neoadjuvant chemotherapy?
Vasileios D Sioulas, Maria B Schiavone, David Kadouri, et al.
Page
of 91